Pemrydi RTU (Pemetrexed) Injection

Pemrydi RTU (pemetrexed), from Dr. Reddy’s Laboratories, is a ready-to-use injectable formulation indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma, in combination with other chemotherapy agents or as maintenance/single-agent therapy.

Pemetrexed is a multi-targeted antifolate that inhibits key enzymes involved in DNA synthesis, disrupting the folate-dependent metabolic pathways that rapidly dividing cancer cells rely on.

• Requires folic acid and vitamin B12 supplementation before and during treatment to reduce toxicity.
• Myelosuppression (low blood counts) is common — regular blood count monitoring is required.
• Renal impairment can increase toxicity; renal function should be monitored.
• Skin reactions can occur; pre-treatment with a corticosteroid may be recommended.
• Concomitant NSAID use may require caution, particularly in patients with renal impairment.

What documents are required to import Pemrydi RTU to India?

Pemrydi RTU may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a registered oncologist
• Diagnostic/pathology report confirming NSCLC or mesothelioma diagnosis
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription.

Is Pemrydi RTU available in India?

Pemrydi RTU (this specific ready-to-use formulation) is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Indian Pharma Network (IPN) can source Pemrydi RTU from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.

For Pemrydi RTU cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: Approved by the FDA (ready-to-use pemetrexed formulation).

What is Pemrydi RTU used for?

Pemrydi RTU treats non-squamous NSCLC and malignant pleural mesothelioma.

Who manufactures Pemrydi RTU?

Pemrydi RTU is manufactured by Dr. Reddy’s Laboratories.

How is Pemrydi RTU administered?

By intravenous infusion, typically once every 21 days, as prescribed by the treating oncologist.

How much does Pemrydi RTU cost in India?

Cost depends on treatment cycles and sourcing logistics — share your prescription with IPN for a quote.